BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4331931)

  • 1. Use of nonhuman primates for vaccine manufacture and control.
    Tauraso NM
    Lab Anim Sci; 1971 Dec; 21(6):1072-3. PubMed ID: 4331931
    [No Abstract]   [Full Text] [Related]  

  • 2. Replacement of animals in manufacture and control of vaccines.
    Hennessen W
    Dev Biol Stand; 1980; 45():163-73. PubMed ID: 6772505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primates--requirements by the pharmaceutical industry.
    Walcroft MJ
    J Med Primatol; 1983; 12(1):1-7. PubMed ID: 6438326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral oncogenesis and results of inoculation of normal and transformed cells into nonhuman primates--discussion.
    Stevenson RE
    Natl Cancer Inst Monogr; 1968 Dec; 29():333-4. PubMed ID: 4976361
    [No Abstract]   [Full Text] [Related]  

  • 5. Human virus vaccines: why monkey cells?
    Science; 1972 May; 176(4036):813-4. PubMed ID: 4624198
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural and experimental infections of nonhuman primates with respiratory viruses.
    Dick EC; Dick CR
    Lab Anim Sci; 1974 Feb; 24(1):177-81. PubMed ID: 4360744
    [No Abstract]   [Full Text] [Related]  

  • 7. Production and evaluation of a formalin-killed Chikungunya vaccine.
    Harrison VR; Eckels KH; Bartelloni PJ; Hampton C
    J Immunol; 1971 Sep; 107(3):643-7. PubMed ID: 4999088
    [No Abstract]   [Full Text] [Related]  

  • 8. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
    Jones SM; Feldmann H; Ströher U; Geisbert JB; Fernando L; Grolla A; Klenk HD; Sullivan NJ; Volchkov VE; Fritz EA; Daddario KM; Hensley LE; Jahrling PB; Geisbert TW
    Nat Med; 2005 Jul; 11(7):786-90. PubMed ID: 15937495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular consistency monitoring of oral poliovirus vaccine and other live viral vaccines.
    Chumakov KM
    Dev Biol Stand; 1999; 100():67-74. PubMed ID: 10616177
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with vaccines produced in the human diploid cell line WI-38.
    Andzaparidze OG
    Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
    [No Abstract]   [Full Text] [Related]  

  • 11. First updated and revised survey of worldwide HIV and SIV vaccine challenge studies in nonhuman primates: progress in first and second order studies.
    Warren JT; Dolatshahi M
    J Med Primatol; 1993; 22(2-3):203-35. PubMed ID: 8411110
    [No Abstract]   [Full Text] [Related]  

  • 12. A nonhuman primate model for preclinical testing of new tuberculosis vaccines.
    McMurray DN
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S210-2. PubMed ID: 10875785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
    Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
    Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
    Vasington PJ
    Natl Cancer Inst Monogr; 1968 Dec; 29():205-6. PubMed ID: 4976358
    [No Abstract]   [Full Text] [Related]  

  • 15. Virologic control of monkeys used for the production of poliomyelitis virus vaccine.
    Osterhaus AD; van Steenis G
    Dev Biol Stand; 1981; 47():157-61. PubMed ID: 6785124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type oncogenic viruses of nonhuman primates.
    Rangan SR
    Lab Anim Sci; 1974 Feb; 24(1):193-203. PubMed ID: 4360745
    [No Abstract]   [Full Text] [Related]  

  • 17. Plaque characterization of viruses from South American nonhuman primates.
    Daniel MD; Meléndez LV; Barahona HH
    J Natl Cancer Inst; 1972 Jul; 49(1):239-49. PubMed ID: 4338774
    [No Abstract]   [Full Text] [Related]  

  • 18. Suggested criteria for the acceptability of a passaged diploid cell population as substrate for virus vaccine production.
    Perkins FT
    Jpn J Med Sci Biol; 1971 Oct; 24(5):336-41. PubMed ID: 5003825
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccines produced in heteroploid cell lines--discussion.
    Hull RN
    Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of nonhuman primates in the development of an AIDS vaccine.
    Nathanson N; Hirsch VM; Mathieson BJ
    AIDS; 1999; 13 Suppl A():S113-20. PubMed ID: 10885770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.